JMP Securities analyst Mitchell Germain maintained a Hold rating on The RMR Group (RMR – Research Report) today. The company’s shares closed ...
JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...